Shares of The Clorox Company (NYSE:CLX – Get Free Report) have earned a consensus rating of “Reduce” from the fifteen analysts that are currently covering the company, Marketbeat Ratings reports. Four analysts have rated the stock with a sell rating and eleven have issued a hold rating on the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $148.00.
A number of equities research analysts have commented on CLX shares. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price target for the company in a research note on Tuesday, March 26th. Barclays lifted their price objective on shares of Clorox from $115.00 to $118.00 and gave the stock an “underweight” rating in a research note on Tuesday, January 16th. Bank of America upgraded Clorox from an “underperform” rating to a “neutral” rating and boosted their price target for the company from $120.00 to $150.00 in a research note on Friday, December 15th. The Goldman Sachs Group began coverage on Clorox in a research note on Friday, March 1st. They issued a “sell” rating and a $140.00 price objective for the company. Finally, JPMorgan Chase & Co. raised their price objective on shares of Clorox from $145.00 to $152.00 and gave the stock a “neutral” rating in a research note on Thursday, January 18th.
Get Our Latest Stock Analysis on Clorox
Institutional Investors Weigh In On Clorox
Clorox Stock Down 1.1 %
NYSE:CLX opened at $144.36 on Tuesday. The company’s 50-day simple moving average is $151.60 and its 200-day simple moving average is $141.16. The company has a debt-to-equity ratio of 11.37, a quick ratio of 0.57 and a current ratio of 0.89. Clorox has a fifty-two week low of $114.68 and a fifty-two week high of $178.21. The stock has a market capitalization of $17.92 billion, a P/E ratio of 229.15, a P/E/G ratio of 2.28 and a beta of 0.43.
Clorox (NYSE:CLX – Get Free Report) last announced its earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. The company had revenue of $1.99 billion during the quarter, compared to the consensus estimate of $1.80 billion. Clorox had a net margin of 1.09% and a return on equity of 319.41%. Clorox’s revenue was up 16.0% compared to the same quarter last year. During the same period last year, the firm earned $0.98 earnings per share. On average, equities analysts anticipate that Clorox will post 5.51 earnings per share for the current fiscal year.
Clorox Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.33%. Clorox’s dividend payout ratio (DPR) is presently 761.92%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- Manufacturing Stocks Investing
- Will the Shockwave Medical Deal Be the Jolt JNJ Stock Needs?
- What Does Downgrade Mean in Investing?
- The 5 Hottest CEO Stock Purchases So Far This Year
- Most Volatile Stocks, What Investors Need to Know
- Institutions Think This Consumer Stock Could Break Higher
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.